Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02766582
What this trial is testing

Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer

Who this might be right for
Ovarian Cancer
Medical College of Wisconsin 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06672068
What this trial is testing

TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC

Who this might be right for
NSCLC
TYK Medicines, Inc 60
Testing effectiveness (Phase 2)Ended earlyNCT00448682
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery

Who this might be right for
Gastric Cancer
University of Miami 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07680790
What this trial is testing

Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 850
Testing effectiveness (Phase 2)Study completedNCT04660097
What this trial is testing

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

Who this might be right for
SCLC, Extensive Stage
Henan Cancer Hospital 34
Testing effectiveness (Phase 2)Looking for participantsNCT06244225
What this trial is testing

HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 38
Testing effectiveness (Phase 2)UnknownNCT02918747
What this trial is testing

PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

Who this might be right for
Lymphoma
Hunan Cancer Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06646055
What this trial is testing

AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Akeso 110
Large-scale testing (Phase 3)Ended earlyNCT00653952
What this trial is testing

CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

Who this might be right for
Ovarian Neoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 220
Testing effectiveness (Phase 2)Looking for participantsNCT07289997
What this trial is testing

Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)

Who this might be right for
AFP Gastric or Gastroesophageal Junction AdenocarcinomaPD-1/CTLA-4AFPGC+1 more
Hebei Medical University Fourth Hospital 39
Testing effectiveness (Phase 2)Looking for participantsNCT07221474
What this trial is testing

Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

Who this might be right for
Squamous Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 180
Not applicableStudy completedNCT01596790
What this trial is testing

COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Montpellier 168
Early research (Phase 1)Looking for participantsNCT07665515
What this trial is testing

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerHGSOCHGS Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Epitopea Ltd 50
Testing effectiveness (Phase 2)Ended earlyNCT00888810
What this trial is testing

Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer

Who this might be right for
CancerOvarianRelapse+1 more
Centre Francois Baclesse 39
Large-scale testing (Phase 3)Not Yet RecruitingNCT07598318
What this trial is testing

Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations

Who this might be right for
Cholangiocarcinoma
Sir Run Run Shaw Hospital 164
Large-scale testing (Phase 3)Study completedNCT07671547
What this trial is testing

Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy

Who this might be right for
Breast CancerHematologic DisorderLeukopenia+1 more
MIPO Clinic 79
Testing effectiveness (Phase 2)Study completedNCT00136955
What this trial is testing

Irinotecan Study For Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Pfizer 41
Testing effectiveness (Phase 2)Ended earlyNCT01732549
What this trial is testing

A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer
Ipsen 144
Testing effectiveness (Phase 2)UnknownNCT00550810
What this trial is testing

Sutent Maintenance After Response to Taxotere

Who this might be right for
Prostate CancerHormone Refractory
Alberta Health services 30
Testing effectiveness (Phase 2)Study completedNCT00651508
What this trial is testing

Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 1
Next Page